$251.10
Price
$16.3B
Market Cap
17.2
P/E Ratio
9.7
Forward P/E
$14.61
EPS (TTM)
—
Dividend Yield
$2.2B
Cash
$5.4B
Total Debt
65M
Shares Out
$123.88
$266.38
52-Week Range
Institutional Ownership of Jazz Pharmaceuticals PLC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| 60.1K | $14M | $171.08 | +46.77% |
Trading Activity for Jazz Pharmaceuticals PLC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q2 | |||||
| SELL | -0.1% | 60.1K | $14M | $226.88 | |
| 2026-Q1 | |||||
| BUY | NEW | 60.2K | $11M | $171.08 | |
| 2024-Q3 | |||||
| SELL | EXIT | — | — | $109.57 | |
| 2024-Q2 | |||||
| BUY | +1.9% | 1.3M | $136M | $109.74 | |
| 2023-Q4 | |||||
| BUY | +23.8% | 833.7K | $103M | $123.36 | |
| 2023-Q2 | |||||
| BUY | +40.7% | 673.7K | $84M | $134.27 | |
| 2023-Q1 | |||||
| BUY | NEW | 478.7K | $70M | $149.41 | |
Insider Trading for Jazz Pharmaceuticals PLC
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.